News

Deal Announcements

Banyan Biomarkers Bags New Venture Equity

Thursday, March 19, 2015 5:32:00 AM PDT | VentureDeal
   Alachua, Florida  --  Biotechnology company Banyan Biomarkers has landed $1.8 million in new venture capital funding, according to an SEC regulatory filing.

Banyan is developing biomarkers to diagnose traumatic brain injuries.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Banyan is still seeking $3.2 million in additional financing, according to the filing.

Eight Investors participated in the financing received.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1